Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:2195-2196

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piette, J.-C.
Right arrow Articles by Cacoub, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piette, J.-C.
Right arrow Articles by Cacoub, P.

(Circulation. 1998;97:2195-2196.)
© 1998 American Heart Association, Inc.


Editorials

Antiphospholipid Syndrome in the Elderly: Caution

Jean-Charles Piette, MD; ; Patrice Cacoub, MD

From the Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

Correspondence to Jean-Charles Piette, Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrière, 83 Boulevard de l'Hôpital, 75651 Paris Cedex 13, France. E-mail jean-charles.piette@psl.ap-hop-paris.fr


Key Words: Editorials • coagulation • immunology • thrombosis • aging

Ten years after its identification, thousands of articles and 2 books have made the APS popular. Subsequently, the diagnosis of a possible APS is now frequently considered in daily practice, not only by subspecialists but also by general practitioners, in patients with thrombosis, sometimes whatever their age at the time of the first vascular event. We wish to emphasize here the potential hazards associated with a diagnosis of APS in elderly patients.

Historically, APS was first identified as a subset of patients with SLE because of the strong association observed in this disorder between the occurrence of thrombosis, either arterial or venous, and/or miscarriages and the presence of aPL (ie, Lupus anticoagulant) and/or aCL. Later, APS was also recognized in patients who had no features of SLE, leading to the concept of a "primary APS."1 A set of criteria has been proposed to discriminate primary from SLE-related APS.2 Although aPL may be encountered in multiple circumstances, primary and SLE-related appear to be the 2 major variants of APS.2 3 4

APS usually affects young patients. This is obviously true for SLE-related APS, given that spontaneously occurring SLE is restricted primarily to women with functional ovaries. This also applies to primary APS, as illustrated by data summarized in the TableDown. In reported series,1 3 4 5 6 7 8 9 10 the first vascular event usually occurs in young adults and rarely in people >60 years old. This age distribution not only reflects a possible bias, ie, the younger the age at first thrombosis, the higher the likelihood of having . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
LupusHome page
A Tincani, M Filippini, M Scarsi, M Galli, and P. Meroni
European attempts for the standardisation of the antiphospholipid antibodies
Lupus, September 1, 2009; 18(10): 913 - 919.
[Abstract] [PDF]


Home page
NeurologyHome page
S. Debiais, I. Bonnaud, N. Ferreira-Maldent, E. Mercier, and B. de Toffol
NEUROPSYCHIATRIC DISORDERS REVEALING PRIMARY ANTIPHOSPHOLIPID SYNDROME IN AN ELDERLY PATIENT
Neurology, April 14, 2009; 72(15): 1362 - 1363.
[Full Text] [PDF]


Home page
LupusHome page
D Ben-Ami, E Bar-Meir, and Y Shoenfeld
Stenosis in Antiphospholipid Syndrome: A New Finding with Clinical Implications
Lupus, July 1, 2006; 15(7): 466 - 472.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
S. R. Sangle, D. P. D'Cruz, I. C. Abbs, M. A. Khamashta, and G. R. V. Hughes
Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation
Rheumatology, March 1, 2005; 44(3): 372 - 377.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M Ramos-Casals, M Garcia-Carrasco, M P Brito, A Lopez-Soto, and J Font
Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly
Lupus, May 1, 2003; 12(5): 341 - 355.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
G Castellino, M J Cuadrado, T Godfrey, M A Khamashta, and G R V Hughes
Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment
Ann Rheum Dis, May 1, 2001; 60(5): 527 - 530.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
M.-H. Yang, F. S. Fan, P.-M. Chen, J.-H. Liu, T.-J. Chiou, W.-S. Wang, and C.-C. Yen
Venous Gangrene in a Patient with Adenocarcinoma of the Lung
Jpn. J. Clin. Oncol., June 1, 2000; 30(6): 276 - 278.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J.-C. Piette, Z. Amoura, and A. Foucher-Lavergne
"Catastrophic" Diagnosis of the Antiphospholipid Syndrome
Ann Intern Med, November 16, 1999; 131(10): 798 - 799.
[Full Text] [PDF]


Home page
LupusHome page
E. Cretel, P. Cacoub, D. L. Thi Huong, A. Gompel, Z. Amoura, and J.-C. Piette
Massive ovarian haemorrhage complicating oral anticoagulation in the Antiphospholipid Syndrome: a report of three cases
Lupus, July 1, 1999; 8(6): 482 - 485.
[Abstract] [PDF]


Home page
LupusHome page
J-C. Piette
Review : Towards improved criteria for the antiphospholipid syndrome
Lupus, January 1, 1998; 7(2_suppl): S149 - S157.
[Abstract] [PDF]